Taymour Hammoudi, MD

For Patients:
My clinical interests are in leveraging patients' existing or transplanted immune system to treat pediatric and young adult cancers. This dovetails with my research interests, which are primarily focused on: (1) profiling and understanding the immune microenvironment of pediatric malignancies; and (2) improving our understanding of how we harness, optimize and drive an augmented immune system after transplant to treat cancer.

For Referring Providers:
My aim as a clinical-translational investigator is to leverage expertise in immunology, cell and tissue engineering and pediatric oncology toward the design and implementation of early and late phase clinical trials centered on cellular and immuno-oncology therapeutics for pediatric and young adult oncology patients so that they may better survive and thrive. My clinical and translational research focuses on developing, implementing and refining cell transplant (SCT) and immune effector cell (IEC) therapies in collaboration with basic scientists and translating novel therapeutic strategies that promote optimal immune reconstitution and function for improving relapse-free survival and long term cure for children with malignancies, marrow failure and disorders of immunity (including discovering biomarkers, applying correlative studies, and evaluating outcomes).